Development of Vorinostat-Loaded Solid Lipid Nanoparticles to Enhance Pharmacokinetics and Efficacy against Multidrug-Resistant Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Vorinostat-Loaded Solid Lipid Nanoparticles to Enhance Pharmacokinetics and Efficacy against Multidrug-Resistant Cancer Cells

Published:2014-02-22 Issue:8 Volume:31 Page:1978-1988
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Tran Tuan Hiep,Ramasamy Thiruganesh,Truong Duy Hieu,Shin Beom Soo,Choi Han-Gon,Yong Chul Soon,Kim Jong Oh

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-014-1300-z.pdf

Reference51 articles.

1. Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol. 2007;25:84–90.

2. Cai YY, Yap CW, Wang Z, Ho PC, Chan SY, Ng KY, et al. Solubilization of vorinostat by cyclodextrins. J Clin Pharm Ther. 2010;35:521–6.

3. Choo QY, Ho PC, Lin HS. Histone deacetylase inhibitors: new hope for rheumatoid arthritis? Curr Pharm Des. 2008;14:803–20.

4. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006;5:769–84.

5. Mohamed EA, Zhao Y, Meshali MM, Remsberg CM, Borg TM, Foda AM, et al. Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-Lactic Acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine. J Pharm Sci. 2012;101:3787–98.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidic Encapsulation of Vorinostat in Calcium Alginate Microparticles: Prolonged Release and Enhanced in vitro Cytotoxicity;ChemistrySelect;2024-01-02

2. Lipid-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

3. Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition;ACS Pharmacology & Translational Science;2023-09-28

4. Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers;Journal of Medicinal Chemistry;2023-04-14

5. A Novel Nanoemulsion Formula for an Improved Delivery of a Thalidomide Analogue to Triple-Negative Breast Cancer; Synthesis, Formulation, Characterization and Molecular Studies;International Journal of Nanomedicine;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3